Reply to Scalone and Cortesi: “Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs”

BioDrugs - Tập 29 - Trang 71-72 - 2015
Federico Spandonaro1, Fabio Ayala2, Enzo Berardesca3, Sergio Chimenti4, Giampiero Girolomoni5, Patrizia Martini6, Andrea Peserico7, Barbara Polistena1, Antonio Puglisi Guerra8, Gino Antonio Vena9, Gianfranco Altomare10, Piergiacomo Calzavara Pinton11
1University of Rome Tor Vergata, Rome, Italy
2Department of Dermatology, University of Naples “Federico II”, Naples, Italy
3San Gallicano Dermatological Institute, Rome, Italy
4Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy
5Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy
6Unit of Dermatology, Lucca Hospital, Lucca, Italy
7Unit of Dermatology, Department of Medicine, University of Padua, Padua, Italy
8Department of Dermatology, Messina Hospital, Messina, Italy
9Unit of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy
10Department of Dermatology, University of Milan, Milan, Italy
11Department of Dermatology, Spedali Civili, Brescia, Italy

Tài liệu tham khảo

Scalone L, Cortesi PA. Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: the importance of using updated and adequate social tariffs to calculate QALYs. Biodrugs. 2015. doi:10.1007/s40259-015-0117-6. Scalone L, Cortesi PA, Ciampichini R, Belisari A, D’Angiolella LS, Cesana G, Mantovani LG. Italian population-based values of EQ-5D health states. Value Health. 2013;16(5):814–22.
Thông tin
Thông tin xuất bản

BioDrugs

Tập 29

71-72

Thông tin tác giả